Association between Anthropometric indices and Cardiometabolic Risk Factors among Women with Primary Infertility

Introduction Sensitive skin is common in acne patients. In these subjects, it important to adopt, whenever possible, a multi-product holistic protocol approach reduce lesions, improve barrier function and ensure good tolerability profile with the final goal of treatment adherence. Study Aim The aim this clinical trial was evaluate efficacy cosmetic regimen improving facial conditions subjects sensitive acne-prone skin. based on use specific cleanser (Biretix Cleanser) antimicrobial activity (biopep15); topical anti-acne product gel formulation containing two retinoid molecules (RetinSpere® technology: hydroxy pinacolone retinoate retinol encapsulated glycospheres) additional anti-inflammatory (niacinamide), antibacterial (biopep15) keratolytic (glycolic salicylic) activities; cream for adjuvant care Hydramat) featuring hydrating, seboregulating renewal actives.The complete (based purify, treat, steps) could be particularly effective where products can often cause excess dryness irritation leading lack patient compliance Subjects Methods study carried out 20 women, aged 18-45 years, prone cleansed applied twice daily, morning evening, used evening both evening. primary outcome evaluation acceptability regimen. Secondary outcomes were sebum production, hydration. Instrumental evaluations by means non-invasive bioengineering techniques. Skin levels measured using Sebumeter® method (Sebumeter 815, Courage+Khazak GmbH). Trans epidermal water loss (TEWL) internationally recognized TEWAMETER® (Tewameter 300® Courage+Khazaka, electronic moisturization evaluated Corneometer®. Visia® pictures taken at baseline after treatments lesions. Results Tested well tolerated all subjects. No adverse reactions or events related observed during study. A significant reduction production (-30%) end period. significantly improved: TEWL reduced 9% week 6. improved an increase 20% 6 comparison baseline. Finally, non inflammatory lesions 26%